Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03748119
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
EB4 | N,N',N''-[(3S,7S,11S)-2,6,10-trioxo- 1,5,9-trioxacyclododecane-3,7,11- triyl]tris(2,3-dihydroxybenzamide) | A,B,C | 3CMP | 0.7 | |
161 | 5-[4-(1-CARBOXYMETHYL-2-OXO-PROPYLCARBAMOYL)- BENZYLSULFAMOYL]-2-HYDROXY-BENZOIC ACID | A,B | 1NMS | 0.72 | |
843 | N-ACETYL-N-[1-(1,1'-BIPHENYL-4- YLMETHYL)-2-OXOAZEPAN-3-YL]-O-PHOSPHONOTYROSINAMIDE | A | 1O42 | 0.71 | |
K55 | (2S)-2-{4-butoxy-3-[({[2-fluoro- 4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]benzyl}butanoic acid | A,B | 2ZNP | 0.72 | |
NLT | N-DODECANOYL-L-TYROSINE | A,B,C,D,E,F, G,H | 2G0B | 0.79 | |
UR2 | 4-[3-CARBOXYMETHYL-3-(4-PHOSPHONOOXY- BENZYL)-UREIDO]-4-[(3-CYCLOHEXYL- PROPYL)-METHYL-CARBAMOYL]BUTYRIC ACID | A | 1SKJ | 0.73 | |
629 | [2-AMINO-3-(4-HYDROXY-PHENYL)-PROPIONYLAMINO]- (1,3,4,5-TETRAHYDROXY-4-HYDROXYMETHYL- PIPERIDIN-2-YL)- ACETIC ACID | A | 1JIJ | 0.7 | |
CMQ | N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)- 2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]- L-LEUCINAMIDE | A,B,C,D,E,F, G,H,I,J,K,L, M,N | 2FZS | 0.72 | |
Y13 | (2E)-3-(3,4-DIHYDROXYPHENYL)-N- [2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE | A | 2EW6 | 0.72 | |
3XH | 3-Hydroxyhippuric acid | A | 3E9K | 0.75 | |
YOF | 3-FLUOROTYROSINE | A,B | 1XIL | 0.74 | |
YOF | 3-FLUOROTYROSINE | A,B | 1XDC | 0.74 | |
YOF | 3-FLUOROTYROSINE | A | 1RRX | 0.74 | |
YOF | 3-FLUOROTYROSINE | A,B | 3FYG | 0.74 | |
099 | (2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)- N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro- 1H-inden-1-yl]butanediamide | A,B | 3HYG | 0.74 | |
IYG | N-ALPHA-ACETYL-3,5-DIIODOTYROSYLGLYCINE | A | 1OPM | 0.73 | |
AJH | 4-({4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]- 1,4-diazepan-1-yl}carbonyl)benzoic acid | A,B | 3EIO | 0.75 | |
CTA | CYCLOTHEONAMIDE A | A | 1TYN | 0.76 | |
072 | (+/-)(2S,5S)-3-(4-(4-CARBOXYPHENYL)BUTYL)- 2-HEPTYL-4-OXO-5-THIAZOLIDINE | A,B,C,D | 4PRG | 0.71 | |
PY9 | 4-{[(2R)-2-(2-methylphenyl)pyrrolidin- 1-yl]carbonyl}benzene-1,3-diol | A,B | 3EKR | 0.78 | |
TI2 | (2-SULFANYL-3-PHENYLPROPANOYL)- PHE-TYR | A | 1QF0 | 0.75 | |
TI3 | [(2S)-2-SULFANYL-3-PHENYLPROPANOYL]- GLY-(5-PHENYLPROLINE) | A | 1QF2 | 0.72 | |
BHP | (S)-5-(4-BENZYLOXY-PHENYL)-4-(7- PHENYL-HEPTANOYLAMINO)-PENTANOIC ACID | A,B | 1J1A | 0.71 | |
D4P | (2S)-AMINO(4-HYDROXYPHENYL)ACETIC ACID | A | 1DSR | 0.76 | |
D4P | (2S)-AMINO(4-HYDROXYPHENYL)ACETIC ACID | A,B,C,D,E,F, G,H | 1W7R | 0.76 | |
D4P | (2S)-AMINO(4-HYDROXYPHENYL)ACETIC ACID | A,B,C,D,E,F, G,H,I,J,K,L | 1W7Q | 0.76 | |
23C | 2-[(1R)-1-carboxy-2-naphthalen- 1-ylethyl]-1,3-dioxo-2,3-dihydro- 1H-isoindole-5-carboxylic acid | A,B | 2R9W | 0.73 | |
CJO | [(2R,4R)-2-[(1R,2R)-1-amino-2-hydroxypropyl]- 4-(4-hydroxybenzyl)-5-oxoimidazolidin- 1-yl]acetic acid | A | 2QT2 | 0.75 | |
TY3 | 3-HYDROXY-L-TYROSINE | A,B | 2VH3 | 0.71 | |
IYT | N-ALPHA-ACETYL-3,5-DIIODOTYROSYL- D-THREONINE | A | 1SDW | 0.7 | |
HA2 | 6-[{(2S)-2-AMINO-3-[4-(BENZYLOXY)PHENYL]PROPYL}(HYDROXY)AMINO]- 6-OXOHEXANOIC ACID) | A | 2VJ8 | 0.7 | |
CS9 | N'-{(1S,2R)-1-(3,5-DIFLUOROBENZYL)- 2-HYDROXY-2-[(2R,4R)-4-PHENOXYPYRROLIDIN- 2-YL]ETHYL}-5-METHYL-N,N-DIPROPYLISOPHTHALAMIDE | A,B | 2QMF | 0.7 | |
EDE | EDEINE B | A,B,D,E,G,H, J,K,L,N,P,Q, R,T | 1I95 | 0.72 | |
CRU | 4-[(4Z)-1-(CARBOXYMETHYL)-4-(4- HYDROXYBENZYLIDENE)-5-OXO-4,5-DIHYDRO- 1H-IMIDAZOL-2-YL]-4-IMINOBUTANOIC ACID | A,B,C,D | 1YZW | 0.7 | |
DRS | (9S,12S)-9-(1-methylethyl)-7,10- dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca- 1(16),14,17-triene-12-carboxylic acid | A,B | 3BXS | 0.7 | |
GAH | N-{[(2S)-1-(N-{[4-({[AMINO(IMINO)METHYL]AMINO}METHYL)CYCLOHEXYL]CARBONYL}- 3-CYCLOHEXYL-L-ALANYL)AZETIDIN- 2-YL]CARBONYL}-L-TYROSYL-N~6~-[AMINO(IMINO)METHYL]- L-LYSINAMIDE | A,H | 1XM1 | 0.71 | |
DEO | A,B | 1ROS | 0.72 | ||
PI5 | N-[3-(8-SEC-BUTYL-7,10-DIOXO-2- OXA-6,9-DIAZA-BICYCLO[11.2.2]HEPTADECA- 1(16),13(17),14- TRIEN-11-YLAMINO)- 2-HYDROXY-1-(4-HYDROXY-BENZYL)- PROPYL]-3-METHYL-2- (2-OXO-PYRROLIDIN- 1-YL)-BUTYRAMIDE | A,B | 1B6K | 0.71 | |
B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A | 3HF0 | 0.72 | |
B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A | 2OXK | 0.72 | |
B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A,B,C | 2OXJ | 0.72 | |
BD2 | 3-[(4-HYDROXYBENZOYL)AMINO]AZEPAN- 4-YL 4-(2-HYDROXYBENZOYL)BENZOATE | A | 1RE8 | 0.7 | |
0E4 | N-acetyl-L-tyrosyl-L-valyl-L-alanyl- L-aspartic acid | B,D | 3GJS | 0.74 | |
ILB | A | 2FPT | 0.7 | ||
098 | (3R)-N~2~-(cyclopropylmethyl)-N~1~- hydroxy-3-(3-hydroxybenzyl)-N~4~- [(1S,2R)-2-hydroxy-2,3-dihydro- 1H-inden-1-yl]-L-aspartamide | A,B | 3HY9 | 0.73 | |
MTY | META-TYROSINE | A | 2TOH | 0.72 | |
MTY | META-TYROSINE | A,B | 1BIQ | 0.72 | |
MTY | META-TYROSINE | A | 1Q7O | 0.72 | |
HV8 | BENZYL-2-AMINO-PARAMETHOXY-BENZYLSTATINE | C | 1A8G | 0.72 | |
IFB | N-[(2',4'-DIFLUORO-4-HYDROXY-5- IODOBIPHENYL-3-YL)CARBONYL]-BETA- ALANINE | A,B | 3FCB | 0.77 | |
TYC | L-TYROSINAMIDE | A | 2BF9 | 0.71 | |
TYC | L-TYROSINAMIDE | A | 2OCI | 0.71 | |
IYR | 3-IODO-TYROSINE | A | 2D98 | 0.71 | |
IYR | 3-IODO-TYROSINE | A | 2D8P | 0.71 | |
IYR | 3-IODO-TYROSINE | A,B | 3GFD | 0.71 | |
IYR | 3-IODO-TYROSINE | A | 2R1Q | 0.71 | |
IYR | 3-IODO-TYROSINE | A | 2ZP1 | 0.71 | |
IYR | 3-IODO-TYROSINE | A,B,C,D | 2ZXV | 0.71 | |
IYR | 3-IODO-TYROSINE | C | 1CF0 | 0.71 | |
IYR | 3-IODO-TYROSINE | A | 1XXZ | 0.71 | |
IYR | 3-IODO-TYROSINE | A | 2D97 | 0.71 | |
IYR | 3-IODO-TYROSINE | A | 1XY9 | 0.71 | |
IYR | 3-IODO-TYROSINE | A | 2Z10 | 0.71 | |
IYR | 3-IODO-TYROSINE | A | 1WQ3 | 0.71 | |
IYR | 3-IODO-TYROSINE | A | 2D8O | 0.71 | |
IYR | 3-IODO-TYROSINE | A | 2D8W | 0.71 | |
IYR | 3-IODO-TYROSINE | A | 2Z11 | 0.71 | |
CRV | N-[1-(AMINOMETHYL)CYCLOPROPYL]- 3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2- TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]- L-ALANINAMIDE | A,B | 2FRA | 0.72 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B | 2AH8 | 0.75 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1HCJ | 0.75 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1W7S | 0.75 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1W7T | 0.75 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B | 2AHA | 0.75 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 1EME | 0.75 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B | 1KP5 | 0.75 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 1EMM | 0.75 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 1EML | 0.75 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1W7U | 0.75 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1EMC | 0.75 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 2HPW | 0.75 | |
CZO | [(2R,4S)-2-[(1S,2R)-1-amino-2-hydroxypropyl]- 2-hydroxy-4-(4-hydroxybenzyl)-5- oxoimidazolidin-1-yl]acetic acid | A | 2QRF | 0.74 | |
YTT | (3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine- 2,5-dione | A | 3G5H | 0.78 | |
TYP | CYCLO-(L-TYROSINE-L-PROLINE) INHIBITOR | A,B | 1W1Y | 0.76 | |
CCY | 2-(1-AMINO-2-MERCAPTO-ETHYL)-5- (4-HYDROXY-BENZYL)-3-(ETHANOYL)- 3,5-DIHYDRO-IMIDAZOL-4-ONE | A | 1EMK | 0.75 | |
ZYA | BENZOYL-TYROSINE-ALANINE-METHYL KETONE | A | 1AIM | 0.76 | |
DTY | D-TYROSINE | A | 1C4B | 0.72 | |
DTY | D-TYROSINE | A,L | 1ZEA | 0.72 | |
DTY | D-TYROSINE | A,B,C,D,E,F, G,H | 1OF6 | 0.72 | |
DTY | D-TYROSINE | A,B | 1UNO | 0.72 | |
DTY | D-TYROSINE | A | 2IGZ | 0.72 | |
DTY | D-TYROSINE | A,B,C,H,K,L | 2R5D | 0.72 | |
DTY | D-TYROSINE | A,B | 2Q33 | 0.72 | |
DTY | D-TYROSINE | H,S | 2H9E | 0.72 | |
DTY | D-TYROSINE | A,B,C,H,K,L | 2R5B | 0.72 | |
DTY | D-TYROSINE | A | 2IH0 | 0.72 | |
DTY | D-TYROSINE | A | 1D7T | 0.72 | |
DTY | D-TYROSINE | A,B | 1XA0 | 0.72 | |
247 | (3R)-3-amino-2,2-difluoro-3-(4- hydroxyphenyl)propanoic acid | A,B | 2QVE | 0.77 | |
B1L | 3-[(4-HYDROXYBENZOYL)AMINO]AZEPAN- 4-YL 4-HYDROXYBENZOATE | A | 1REJ | 0.72 | |
TTS | 3-((3E)-4-HYDROXY-3-{[2-(4-HYDROXYPHENYL)ETHYL]IMINO}- 6-OXOCYCLOHEXA-1,4-DIEN-1-YL)ALANINE | A,B | 2D1W | 0.71 | |
1C5 | [[O-PHOSPHONO-N-ACETYL-TYROSINYL]- GLUTAMYL-3[CYCLOHEXYLMETHYL]ALANINYL]- AMINE | A | 1BKM | 0.74 | |
DBS | 2-(2,3-DIHYDROXY-BENZOYLAMINO)- 3-HYDROXY-PROPIONIC ACID | A,B,C | 1L6M | 0.7 | |
DBS | 2-(2,3-DIHYDROXY-BENZOYLAMINO)- 3-HYDROXY-PROPIONIC ACID | A,B,C | 3CBC | 0.7 | |
DBS | 2-(2,3-DIHYDROXY-BENZOYLAMINO)- 3-HYDROXY-PROPIONIC ACID | A,B,C | 3BY0 | 0.7 | |
SD2 | N-(SULFANYLACETYL)TYROSYLPROLYLMETHIONINAMIDE | A,B | 1PWQ | 0.73 | |
DK2 | 2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]- 1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID | A,B | 2PU2 | 0.83 | |
DGH | (2R)-AMINO(4-HYDROXYPHENYL)ACETIC ACID | A,B,C,D,E,F, G,H,I,J,K,L | 1W7Q | 0.76 | |
DGH | (2R)-AMINO(4-HYDROXYPHENYL)ACETIC ACID | A,B,C,D,E,F, G,H | 1W7R | 0.76 | |
WH6 | 2-[(1R)-2-carboxy-1-(naphthalen- 1-ylmethyl)ethyl]-1,3-dioxo-2,3- dihydro-1H-isoindole-5-carboxylic acid | A,B | 2R9X | 0.73 | |
K57 | 3-[2-HYDROXY-3-(3-HYDROXY-2-METHYL- BENZOYLAMINO)-4-PHENYL-BUTYRYL]- 5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID TERT- BUTYLAMIDE | B | 1MRX | 0.71 | |
K57 | 3-[2-HYDROXY-3-(3-HYDROXY-2-METHYL- BENZOYLAMINO)-4-PHENYL-BUTYRYL]- 5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID TERT- BUTYLAMIDE | A | 1MRW | 0.71 | |
4MP | 1-(4-METHOXYBENZOYL)-2-PYRROLIDINONE | A,B | 2AL5 | 0.72 | |
DAH | 3,4-DIHYDROXYPHENYLALANINE | A,B | 1RNR | 0.71 | |
DAH | 3,4-DIHYDROXYPHENYLALANINE | A | 6PAH | 0.71 | |
DAH | 3,4-DIHYDROXYPHENYLALANINE | A,B | 1IVV | 0.71 | |
AXL | 2-{1-[2-AMINO-2-(4-HYDROXY-PHENYL)- ACETYLAMINO]-2-OXO-ETHYL}-5,5-DIMETHYL- THIAZOLIDINE-4-CARBOXYLIC ACID | B | 1LL9 | 0.75 | |
401 | (2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]- 4-methoxybenzyl}butanoic acid | A,B | 2ZNQ | 0.74 | |
GHP | 4-HYDROXYPHENYLGLYCINE | A | 1DSR | 0.76 | |
UA1 | N-(TERT-BUTOXYCARBONYL)-L-TYROSYL- N-METHYL-4-(SULFOAMINO)-L-PHENYLALANINAMIDE | A | 2I4H | 0.71 | |
UA1 | N-(TERT-BUTOXYCARBONYL)-L-TYROSYL- N-METHYL-4-(SULFOAMINO)-L-PHENYLALANINAMIDE | A | 2I4G | 0.71 | |
YBY | N-{[(1S)-1-carboxy-2-(4-hydroxy- 3-iodophenyl)ethyl]carbamoyl}-L- glutamic acid | A | 3D7F | 0.72 | |
IFA | A,B | 3FC8 | 0.75 | ||
CFY | [(2S)-2-{(2R)-2-[(1S)-1-amino-2- phenylethyl]-2-hydroxy-2,5-dihydro- 1,3-thiazol-4-yl}-4-(4-hydroxybenzyl)- 5-oxo-2,5-dihydro-1H-imidazol-1- yl]acetic acid | A,B,C,D | 2ZMW | 0.7 | |
CFY | [(2S)-2-{(2R)-2-[(1S)-1-amino-2- phenylethyl]-2-hydroxy-2,5-dihydro- 1,3-thiazol-4-yl}-4-(4-hydroxybenzyl)- 5-oxo-2,5-dihydro-1H-imidazol-1- yl]acetic acid | A | 2ZMU | 0.7 | |
C1N | N-[(BENZYLOXY)CARBONYL]LEUCYL-N~1~- [3-FLUORO-1-(4-HYDROXYBENZYL)-2- OXOPROPYL]LEUCINAMIDE | A | 1ZCM | 0.77 | |
DMC | 3-(4-DIETHYLAMINO-2-HYDROXY-PHENYL)- 2-METHYL-PROPIONIC ACID | G | 4GCH | 0.7 | |
ARY | ARYLOMYCIN A2 | A,B | 1T7D | 0.76 | |
296 | (3R)-3-amino-2,2-difluoro-3-(4- methoxyphenyl)propanoic acid | A,B | 2RJS | 0.7 | |
BFS | N-[1-(4-BROMOPHENYL)ETHYL]-5-FLUORO SALICYLAMIDE | A | 1STD | 0.73 | |
BFS | N-[1-(4-BROMOPHENYL)ETHYL]-5-FLUORO SALICYLAMIDE | A,B,C | 4STD | 0.73 | |
BJP | (1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID | A | 1ERO | 0.71 |